Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Multicenter, Open-label, Phase 2 Study of Imprime PGG and Pembrolizumab in Patients with Metastatic Breast Cancer (mBCA) Who Have Progressed Through Prior Hormonal Therapy
Sponsored by Criterium Inc
Active
$185.5K Funding
4 People
External
Related Topics
cancer immunotherapy,
metastatic breast cancer,
immunotherapy combinations,
hormone therapy resistance
People
Sylvia DeCero
(CD)
Cancer Center Division
﹒Research Nurse III
Fernanda Sanchez Borchardt
(CD)
Social & Behavioral Sci Admin
﹒Administrative Operations Professional II
Carolyn Lane
(CD)
Cancer Center Division
﹒Research Laboratory Manager I
Niyuri Fleming
(CD)
Cancer Center Division
﹒Clinical Research Manager I
